These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8647475)

  • 1. Cervical cancer: how often--and why--to screen older women.
    Mandelblatt JS; Phillips RN
    Geriatrics; 1996 Jun; 51(6):45-8; quiz 49. PubMed ID: 8647475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Women at risk: papanicolaou smear screening in Florida.
    Vincent AL; Greene JN; Hoercherl S; McTague D
    J Fla Med Assoc; 1997; 84(5):302-7. PubMed ID: 9260433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Women's attitudes to and awareness of smear testing and cervical cancer.
    Yu CK; Rymer J
    Br J Fam Plann; 1998 Jan; 23(4):127-33. PubMed ID: 9882766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cervical cancer screening and the older woman: obstacles and opportunities.
    Brooks SE
    Cancer Pract; 1996; 4(3):125-9. PubMed ID: 8826140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cervical cancer in women with comprehensive health care access: attributable factors in the screening process.
    Leyden WA; Manos MM; Geiger AM; Weinmann S; Mouchawar J; Bischoff K; Yood MU; Gilbert J; Taplin SH
    J Natl Cancer Inst; 2005 May; 97(9):675-83. PubMed ID: 15870438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of cervical cancer screening program at a rural community of South Africa.
    Hoque M; Hoque E; Kader SB
    East Afr J Public Health; 2008 Aug; 5(2):111-6. PubMed ID: 19024420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Why women still die from cervical cancer.
    Masood S
    J Fla Med Assoc; 1997; 84(6):379-83. PubMed ID: 9379163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for cervical cancer: will women accept less?
    Sirovich BE; Woloshin S; Schwartz LM
    Am J Med; 2005 Feb; 118(2):151-8. PubMed ID: 15694900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The importance of health insurance as a determinant of cancer screening: evidence from the Women's Health Initiative.
    Hsia J; Kemper E; Kiefe C; Zapka J; Sofaer S; Pettinger M; Bowen D; Limacher M; Lillington L; Mason E
    Prev Med; 2000 Sep; 31(3):261-70. PubMed ID: 10964640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Report from the CDC. Pap test intervals used by physicians serving low-income women through the National Breast and Cervical Cancer Early Detection Program.
    Cooper CP; Saraiya M; McLean TA; Hannan J; Liesmann JM; Rose SW; Lawson HW
    J Womens Health (Larchmt); 2005 Oct; 14(8):670-8. PubMed ID: 16232098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beyond the Pap: assessing patients' priorities for the annual examination.
    Becker HI; Longacre MR; Harper DM
    J Womens Health (Larchmt); 2004 Sep; 13(7):791-8. PubMed ID: 15385073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cervical cancer screening among elderly urban women in a primary care setting.
    Wong QC; Collins R; Kalkstein K; Roth A; Gintautas J
    Proc West Pharmacol Soc; 2005; 48():154-6. PubMed ID: 16416686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cervical cancer screening program of Paraná: cost-effective model in a developing country.
    Bleggi Torres LF; Werner B; Totsugui J; Collaço LM; Araújo SR; Huçulak M; Boza EJ; Fischer RM; De Laat L; Sobbania LC; Raggio A
    Diagn Cytopathol; 2003 Jul; 29(1):49-54. PubMed ID: 12827718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of adding human papilloma virus testing to a managed care cervical cancer screening program.
    Lonky NM; Hunter MI; Sadeghi M; Edwards G; Bajamundi K; Monk BJ
    J Low Genit Tract Dis; 2007 Oct; 11(4):258-64. PubMed ID: 17917570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing the role of education in women's knowledge and acceptance of adjunct high-risk human Papillomavirus testing for cervical cancer screening.
    Papa D; Moore Simas TA; Reynolds M; Melnitsky H
    J Low Genit Tract Dis; 2009 Apr; 13(2):66-71. PubMed ID: 19387125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cervical cancer screening among U.S. women: analyses of the 2000 National Health Interview Survey.
    Hewitt M; Devesa SS; Breen N
    Prev Med; 2004 Aug; 39(2):270-8. PubMed ID: 15226035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
    Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
    J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pap smear screening among urban Southwestern American Indian women.
    Risendal B; DeZapien J; Fowler B; Papenfuss M; Giuliano A
    Prev Med; 1999 Dec; 29(6 Pt 1):510-8. PubMed ID: 10600432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pap screening in a U.S. health plan.
    Insinga RP; Glass AG; Rush BB
    Cancer Epidemiol Biomarkers Prev; 2004 Mar; 13(3):355-60. PubMed ID: 15006908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of visual inspection and Papanicolau (PAP) smears for cervical cancer screening in Honduras: should PAP smears be abandoned?
    Perkins RB; Langrish SM; Stern LJ; Figueroa J; Simon CJ
    Trop Med Int Health; 2007 Sep; 12(9):1018-25. PubMed ID: 17875013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.